Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Baum

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Dalton Transactions (Cambridge, England : 2003)|March 30, 2011
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICSFrank Rösch, Richard P Baum
PET Clinics|July 18, 2014
Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapyMatthias Blaickner, Richard P Baum
World Journal of Nuclear Medicine|October 29, 2011
1 World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, GermanyRichard P Baum, Frank Rösch
PET Clinics|March 8, 2017
Prostate Cancer Imaging in the Era of Molecular MedicineRichard P Baum, Cristina Nanni
European Journal of Nuclear Medicine and Molecular Imaging|December 24, 2008
Multimodality image registration with software: state-of-the-artPiotr J Slomka, Richard P Baum
PET Clinics|July 18, 2014
Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapyHarshad R Kulkarni, Richard P Baum
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed TheranosticsWolfgang P Fendler, Richard P Baum
Theranostics|July 7, 2012
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka ExperienceRichard P Baum, Harshad R Kulkarni
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Standard imaging techniques for neuroendocrine tumorsDavid L Bushnell, Richard P Baum
Clinical Nuclear Medicine|November 12, 2013
Successful treatment of metastasized pancreatic vasoactive intestinal polypeptide-secreting tumor unresponsive to high-dose octreotide by peptide receptor radionuclide therapy using 90Y DOTATATEAurora Sainz-Esteban, Richard P Baum
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Dalton Transactions (Cambridge, England : 2003)|March 30, 2011
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICSFrank Rösch, Richard P Baum
PET Clinics|July 18, 2014
Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapyMatthias Blaickner, Richard P Baum
World Journal of Nuclear Medicine|October 29, 2011
1 World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, GermanyRichard P Baum, Frank Rösch
PET Clinics|March 8, 2017
Prostate Cancer Imaging in the Era of Molecular MedicineRichard P Baum, Cristina Nanni
European Journal of Nuclear Medicine and Molecular Imaging|December 24, 2008
Multimodality image registration with software: state-of-the-artPiotr J Slomka, Richard P Baum
PET Clinics|July 18, 2014
Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapyHarshad R Kulkarni, Richard P Baum
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed TheranosticsWolfgang P Fendler, Richard P Baum
Theranostics|July 7, 2012
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka ExperienceRichard P Baum, Harshad R Kulkarni
Endocrinology and Metabolism Clinics of North America|February 26, 2011
Standard imaging techniques for neuroendocrine tumorsDavid L Bushnell, Richard P Baum
Clinical Nuclear Medicine|November 12, 2013
Successful treatment of metastasized pancreatic vasoactive intestinal polypeptide-secreting tumor unresponsive to high-dose octreotide by peptide receptor radionuclide therapy using 90Y DOTATATEAurora Sainz-Esteban, Richard P Baum
Pageof 20